Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Bond

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Cureus|December 8, 2025
Modified Marshall Score: An Underutilised Prognostication Tool for Acute PancreatitisCharles Her Yi Ling, Richard Bond, Simon East, et al.
BMJ Case Reports|July 7, 2012
Lost without Occam's razor: Escherichia coli tricuspid valve endocarditis in a non-intravenous drug userJo-Ai Foley, Daniel Augustine, Richard Bond, et al.
ANZ Journal of Surgery|April 18, 2012
Branch thoracic stent graft repair for arch aneurysmBrendan M Stanley, Kurian J Mylankal, Jonathan Tibballs, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2004
Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damageAndrew Webb, Richard Bond, Peter McLean, et al.
Current Opinion in Pharmacology|April 1, 2014
Ligand bias prevents class equality among beta-blockersVaidehi J Thanawala, Gloria S Forkuo, Wayne Stallaert, et al.
Cancer Letters|November 2, 2010
Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastasesMichelle L Varney, Seema Singh, Aihua Li, et al.
Trends in Pharmacological Sciences|June 29, 2004
Subtype-specific beta-adrenoceptor signaling pathways in the heart and their potential clinical implicationsRui-Ping Xiao, Weizhong Zhu, Ming Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2009
Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesisSeema Singh, Anguraj Sadanandam, Kalyan C Nannuru, et al.
Frontiers in Cardiovascular Medicine|May 21, 2020
COVID-19 Management and Arrhythmia: Risks and Challenges for Clinicians Treating Patients Affected by SARS-CoV-2Alexander Carpenter, Owen J Chambers, Aziza El Harchi, et al.
Bioorganic & Medicinal Chemistry Letters|October 5, 2013
Discovery of pyrazolo[1,5-a]pyrimidine-based Pim inhibitors: a template-based approachMichael P Dwyer, Kartik Keertikar, Kamil Paruch, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Cureus|December 8, 2025
Modified Marshall Score: An Underutilised Prognostication Tool for Acute PancreatitisCharles Her Yi Ling, Richard Bond, Simon East, et al.
BMJ Case Reports|July 7, 2012
Lost without Occam's razor: Escherichia coli tricuspid valve endocarditis in a non-intravenous drug userJo-Ai Foley, Daniel Augustine, Richard Bond, et al.
ANZ Journal of Surgery|April 18, 2012
Branch thoracic stent graft repair for arch aneurysmBrendan M Stanley, Kurian J Mylankal, Jonathan Tibballs, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2004
Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damageAndrew Webb, Richard Bond, Peter McLean, et al.
Current Opinion in Pharmacology|April 1, 2014
Ligand bias prevents class equality among beta-blockersVaidehi J Thanawala, Gloria S Forkuo, Wayne Stallaert, et al.
Cancer Letters|November 2, 2010
Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastasesMichelle L Varney, Seema Singh, Aihua Li, et al.
Trends in Pharmacological Sciences|June 29, 2004
Subtype-specific beta-adrenoceptor signaling pathways in the heart and their potential clinical implicationsRui-Ping Xiao, Weizhong Zhu, Ming Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2009
Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesisSeema Singh, Anguraj Sadanandam, Kalyan C Nannuru, et al.
Frontiers in Cardiovascular Medicine|May 21, 2020
COVID-19 Management and Arrhythmia: Risks and Challenges for Clinicians Treating Patients Affected by SARS-CoV-2Alexander Carpenter, Owen J Chambers, Aziza El Harchi, et al.
Bioorganic & Medicinal Chemistry Letters|October 5, 2013
Discovery of pyrazolo[1,5-a]pyrimidine-based Pim inhibitors: a template-based approachMichael P Dwyer, Kartik Keertikar, Kamil Paruch, et al.
Pageof 4